Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Biomarkers”

359 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 359 results

Not applicableUnknownNCT03175146
What this trial is testing

See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely

Who this might be right for
Colonic NeoplasmsNeoplasm Metastasis
AHS Cancer Control Alberta 30
Not applicableNot Yet RecruitingNCT06836518
What this trial is testing

Sialic Acid in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sohag University 100
Not applicableStudy completedNCT04058327
What this trial is testing

MHE in Patients With Liver Diseases

Who this might be right for
Hepatic EncephalopathyMinimal Hepatic EncephalopathyOvert Hepatic Encephalopathy
Qin Ning 252
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableActive Not RecruitingNCT06011356
What this trial is testing

Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study

Who this might be right for
Cardiovascular DiseasesNon-Alcoholic Fatty Liver DiseaseRespiratory Disease+1 more
Imperial College London 1,000
Not applicableUnknownNCT06272656
What this trial is testing

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hebei Medical University Third Hospital 200
Not applicableLooking for participantsNCT06382103
What this trial is testing

Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 240
Early research (Phase 1)Active Not RecruitingNCT03278925
What this trial is testing

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Who this might be right for
Cirrhosis
National Cancer Institute (NCI) 14
Not applicableStudy completedNCT05497765
What this trial is testing

An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Guangzhou Medical University 94
Not applicableStudy completedNCT03804593
What this trial is testing

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Who this might be right for
Cirrhosis, LiverHepatic CirrhosisHepatocellular Carcinoma+1 more
Epigenomics, Inc 175
Not applicableStudy completedNCT01276899
What this trial is testing

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Jewish General Hospital 80
Not applicableWithdrawnNCT05653531
What this trial is testing

Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Immune Checkpoint InhibitorLung CancerLiver Biomarkers+1 more
Centre Hospitalier Universitaire, Amiens
Not applicableStudy completedNCT04341012
What this trial is testing

Breath Analysis Based Disease Biomarkers

Who this might be right for
Liver DiseasesLiver CancerCOVID19
Mayo Clinic 46
Not applicableStudy completedNCT02201797
What this trial is testing

Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Who this might be right for
Metastatic Liver Cancer
Asan Medical Center 13
Not applicableStudy completedNCT04575506
What this trial is testing

Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesityMetabolic Syndrome
Universidad Pública de Navarra 60
Not applicableWithdrawnNCT06144827
What this trial is testing

A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Who this might be right for
Cancer, HepatocellularRadiotherapy Side Effect
Montefiore Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Not applicableStudy completedNCT06253364
What this trial is testing

VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy

Who this might be right for
HCCRecurrence
Chen Xiaoping 462
Not applicableUnknownNCT03020342
What this trial is testing

HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC

Who this might be right for
Carcinoma, Hepatocellular
National Taiwan University Hospital 50
Load More Results